-+ 0.00%
-+ 0.00%
-+ 0.00%

Raymond James Maintains Outperform on Haemonetics, Raises Price Target to $125

Benzinga·09/03/2026 18:25:56
Listen to the news
Raymond James analyst Andrew Cooper maintains Haemonetics (NYSE:HAE) with a Outperform and raises the price target from $105 to $125.